Abstract and Introduction Clinical Profile of Aripiprazole as Reflected by Clinical Trial Data Use of Aripiprazole in the Treatment of Schizophrenia: Consensus Report Conclusion References Control ...
The novel atypical antipsychotic agent aripiprazole is a partial agonist at D 2 receptors that has been shown in clinical trials to be effective in treating both the positive and the negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback